▶ 調査レポート

世界の虚血性脳卒中の治療市場：市場規模・現状・予測
• 英文タイトル：Global Ischemic Stroke Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の虚血性脳卒中の治療市場：市場規模・現状・予測 / Global Ischemic Stroke Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9N7414資料のイメージです。• レポートコード：QYR9N7414
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、虚血性脳卒中の治療のグローバル市場について調査・分析したレポートで、種類別（組織プラスミノーゲンアクチベーター、抗凝固薬、抗血小板、降圧薬、その他）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・虚血性脳卒中の治療の世界市場規模
・主要企業別市場シェア
・虚血性脳卒中の治療の世界市場規模：種類別（組織プラスミノーゲンアクチベーター、抗凝固薬、抗血小板、降圧薬、その他）
・虚血性脳卒中の治療の世界市場規模：用途別（病院、診療所、外来手術センター、その他）
・虚血性脳卒中の治療のアメリカ市場規模（種類別、用途別）
・虚血性脳卒中の治療のヨーロッパ市場規模（種類別、用途別）
・虚血性脳卒中の治療の中国市場規模（種類別、用途別）
・虚血性脳卒中の治療の日本市場規模（種類別、用途別）
・虚血性脳卒中の治療の東南アジア市場規模（種類別、用途別）
・虚血性脳卒中の治療のインド市場規模（種類別、用途別）
・虚血性脳卒中の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・虚血性脳卒中の治療の世界市場予測（2019年-2025年）
・虚血性脳卒中の治療の地域別市場予測（2019年-2025年）
...

Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.In 2018, the global Ischemic Stroke Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ischemic Stroke Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ischemic Stroke Therapeutics development in United States, Europe and China.

The key players covered in this study
Pfizer
Merck
Boehringer Ingelheim
Sanofi
Johnson & Johnson
Bayer
Biogen
Abbott Laboratories
Genentech
Daiichi Sankyo

Market segment by Type, the product can be split into
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Others

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ischemic Stroke Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Ischemic Stroke Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ischemic Stroke Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ischemic Stroke Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Tissue Plasminogen Activator
1.4.3 Anticoagulant
1.4.4 Antiplatelet
1.4.5 Antihypertensive
1.4.6 Others
1.5 Market by Application
1.5.1 Global Ischemic Stroke Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Ischemic Stroke Therapeutics Market Size
2.2 Ischemic Stroke Therapeutics Growth Trends by Regions
2.2.1 Ischemic Stroke Therapeutics Market Size by Regions (2014-2025)
2.2.2 Ischemic Stroke Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Ischemic Stroke Therapeutics Market Size by Manufacturers
3.1.1 Global Ischemic Stroke Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Ischemic Stroke Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ischemic Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Ischemic Stroke Therapeutics Key Players Head office and Area Served
3.3 Key Players Ischemic Stroke Therapeutics Product/Solution/Service
3.4 Date of Enter into Ischemic Stroke Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Ischemic Stroke Therapeutics Market Size by Type (2014-2019)
4.2 Global Ischemic Stroke Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Ischemic Stroke Therapeutics Market Size (2014-2019)
5.2 Ischemic Stroke Therapeutics Key Players in United States
5.3 United States Ischemic Stroke Therapeutics Market Size by Type
5.4 United States Ischemic Stroke Therapeutics Market Size by Application

6 Europe
6.1 Europe Ischemic Stroke Therapeutics Market Size (2014-2019)
6.2 Ischemic Stroke Therapeutics Key Players in Europe
6.3 Europe Ischemic Stroke Therapeutics Market Size by Type
6.4 Europe Ischemic Stroke Therapeutics Market Size by Application

7 China
7.1 China Ischemic Stroke Therapeutics Market Size (2014-2019)
7.2 Ischemic Stroke Therapeutics Key Players in China
7.3 China Ischemic Stroke Therapeutics Market Size by Type
7.4 China Ischemic Stroke Therapeutics Market Size by Application

8 Japan
8.1 Japan Ischemic Stroke Therapeutics Market Size (2014-2019)
8.2 Ischemic Stroke Therapeutics Key Players in Japan
8.3 Japan Ischemic Stroke Therapeutics Market Size by Type
8.4 Japan Ischemic Stroke Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Ischemic Stroke Therapeutics Market Size (2014-2019)
9.2 Ischemic Stroke Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Ischemic Stroke Therapeutics Market Size by Type
9.4 Southeast Asia Ischemic Stroke Therapeutics Market Size by Application

10 India
10.1 India Ischemic Stroke Therapeutics Market Size (2014-2019)
10.2 Ischemic Stroke Therapeutics Key Players in India
10.3 India Ischemic Stroke Therapeutics Market Size by Type
10.4 India Ischemic Stroke Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Ischemic Stroke Therapeutics Market Size (2014-2019)
11.2 Ischemic Stroke Therapeutics Key Players in Central & South America
11.3 Central & South America Ischemic Stroke Therapeutics Market Size by Type
11.4 Central & South America Ischemic Stroke Therapeutics Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ischemic Stroke Therapeutics Introduction
12.1.4 Pfizer Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ischemic Stroke Therapeutics Introduction
12.2.4 Merck Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ischemic Stroke Therapeutics Introduction
12.3.4 Boehringer Ingelheim Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ischemic Stroke Therapeutics Introduction
12.4.4 Sanofi Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ischemic Stroke Therapeutics Introduction
12.5.4 Johnson & Johnson Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ischemic Stroke Therapeutics Introduction
12.6.4 Bayer Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Biogen
12.7.1 Biogen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ischemic Stroke Therapeutics Introduction
12.7.4 Biogen Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.7.5 Biogen Recent Development
12.8 Abbott Laboratories
12.8.1 Abbott Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ischemic Stroke Therapeutics Introduction
12.8.4 Abbott Laboratories Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.8.5 Abbott Laboratories Recent Development
12.9 Genentech
12.9.1 Genentech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Ischemic Stroke Therapeutics Introduction
12.9.4 Genentech Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.9.5 Genentech Recent Development
12.10 Daiichi Sankyo
12.10.1 Daiichi Sankyo Company Details
12.10.2 Company Description and Business Overview
12.10.3 Ischemic Stroke Therapeutics Introduction
12.10.4 Daiichi Sankyo Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.10.5 Daiichi Sankyo Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Ischemic Stroke Therapeutics Key Market Segments
Table Key Players Ischemic Stroke Therapeutics Covered
Table Global Ischemic Stroke Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Ischemic Stroke Therapeutics Market Size Market Share by Type 2014-2025
Figure Tissue Plasminogen Activator Figures
Table Key Players of Tissue Plasminogen Activator
Figure Anticoagulant Figures
Table Key Players of Anticoagulant
Figure Antiplatelet Figures
Table Key Players of Antiplatelet
Figure Antihypertensive Figures
Table Key Players of Antihypertensive
Figure Others Figures
Table Key Players of Others
Table Global Ischemic Stroke Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Ischemic Stroke Therapeutics Report Years Considered
Table Global Ischemic Stroke Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Ischemic Stroke Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Ischemic Stroke Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Ischemic Stroke Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Ischemic Stroke Therapeutics Market Share by Regions 2014-2019
Figure Global Ischemic Stroke Therapeutics Market Share by Regions 2014-2019
Figure Global Ischemic Stroke Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Ischemic Stroke Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Ischemic Stroke Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Ischemic Stroke Therapeutics Market Share by Manufacturers in 2018
Table Global Ischemic Stroke Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Ischemic Stroke Therapeutics Product/Solution/Service
Table Date of Enter into Ischemic Stroke Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Ischemic Stroke Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Ischemic Stroke Therapeutics Market Size Share by Type (2014-2019)
Figure Global Ischemic Stroke Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Ischemic Stroke Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Ischemic Stroke Therapeutics Market Size Share by Application (2014-2019)
Figure Global Ischemic Stroke Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Ischemic Stroke Therapeutics Revenue Market Share by Application in 2018
Figure United States Ischemic Stroke Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Ischemic Stroke Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Ischemic Stroke Therapeutics Market Share (2018-2019)
Table United States Ischemic Stroke Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Ischemic Stroke Therapeutics Market Share by Type (2014-2019)
Table United States Ischemic Stroke Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Ischemic Stroke Therapeutics Market Share by Application (2014-2019)
Figure Europe Ischemic Stroke Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Ischemic Stroke Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Ischemic Stroke Therapeutics Market Share (2018-2019)
Table Europe Ischemic Stroke Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Ischemic Stroke Therapeutics Market Share by Type (2014-2019)
Table Europe Ischemic Stroke Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Ischemic Stroke Therapeutics Market Share by Application (2014-2019)
Figure China Ischemic Stroke Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Ischemic Stroke Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Ischemic Stroke Therapeutics Market Share (2018-2019)
Table China Ischemic Stroke Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Ischemic Stroke Therapeutics Market Share by Type (2014-2019)
Table China Ischemic Stroke Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Ischemic Stroke Therapeutics Market Share by Application (2014-2019)
Figure Japan Ischemic Stroke Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Ischemic Stroke Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Ischemic Stroke Therapeutics Market Share (2018-2019)
Table Japan Ischemic Stroke Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Ischemic Stroke Therapeutics Market Share by Type (2014-2019)
Table Japan Ischemic Stroke Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Ischemic Stroke Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Ischemic Stroke Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Ischemic Stroke Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Ischemic Stroke Therapeutics Market Share (2018-2019)
Table Southeast Asia Ischemic Stroke Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Ischemic Stroke Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Ischemic Stroke Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Ischemic Stroke Therapeutics Market Share by Application (2014-2019)
Figure India Ischemic Stroke Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Ischemic Stroke Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Ischemic Stroke Therapeutics Market Share (2018-2019)
Table India Ischemic Stroke Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Ischemic Stroke Therapeutics Market Share by Type (2014-2019)
Table India Ischemic Stroke Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Ischemic Stroke Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Ischemic Stroke Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Ischemic Stroke Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Ischemic Stroke Therapeutics Market Share (2018-2019)
Table Central & South America Ischemic Stroke Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Ischemic Stroke Therapeutics Market Share by Type (2014-2019)
Table Central & South America Ischemic Stroke Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Ischemic Stroke Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Ischemic Stroke Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Bayer Company Details
Table Bayer Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Biogen Company Details
Table Biogen Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Biogen Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Genentech Company Details
Table Genentech Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Genentech Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Ischemic Stroke Therapeutics Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Ischemic Stroke Therapeutics Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Global Ischemic Stroke Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Ischemic Stroke Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Ischemic Stroke Therapeutics Market Size Share by Regions in 2025
Figure United States Ischemic Stroke Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Ischemic Stroke Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Ischemic Stroke Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Ischemic Stroke Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Ischemic Stroke Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Ischemic Stroke Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Ischemic Stroke Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Ischemic Stroke Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Ischemic Stroke Therapeutics Market Size by Product (2019-2025)
Figure Global Ischemic Stroke Therapeutics Market Size by Product in 2025
Table Global Ischemic Stroke Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Ischemic Stroke Therapeutics Market Size by Application (2019-2025)
Figure Global Ischemic Stroke Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界のデジタル治療薬＆ウェルネス市場：市場規模・現状・予測
    Global Digital Therapeutics & Wellness Market Size, Status and Forecast 2019-2025
    QYR9N7107 2019年6月14日 107Pages
    当資料は、デジタル治療薬＆ウェルネスのグローバル市場について調査・分析したレポートで、種類別（ソフトウェア、デバイス）、用途別（心血管疾患と高血圧、糖尿病と前糖尿病、肥満と減量、禁煙、その他のデジタル治療学）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...
  • 世界の骨粗鬆症治療薬市場：市場規模・現状・予測
    Global Osteoporosis Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7734 2019年6月14日 94Pages
    当資料は、骨粗鬆症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗吸収薬、同化薬）、用途別（男性、女性）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・骨粗鬆症治療薬の...
  • 世界の脂質異常症治療薬市場：市場規模・現状・予測
    Global Dyslipidemia Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7136 2019年6月14日 93Pages
    当資料は、脂質異常症治療薬のグローバル市場について調査・分析したレポートで、種類別（スタチン、非スタチン、組み合わせ薬）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。<...
  • 世界の胃炎治療薬市場：市場規模・現状・予測
    Global Gastritis Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7226 2019年6月14日 96Pages
    当資料は、胃炎治療薬のグローバル市場について調査・分析したレポートで、種類別（酸遮断薬、抗生物質、制酸剤、ヒスタミンブロッカー、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の変形性関節症治療市場：市場規模・現状・予測
    Global Osteoarthritis Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7733 2019年6月14日 103Pages
    当資料は、変形性関節症治療のグローバル市場について調査・分析したレポートで、種類別（経口、注入、外部）、用途別（医療、パーソナルケア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・変形...
  • 世界の過活動膀胱治療学市場：市場規模・現状・予測
    Global Overactive Bladder Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7750 2019年6月14日 92Pages
    当資料は、過活動膀胱治療学のグローバル市場について調査・分析したレポートで、種類別（抗コリン作用薬、ミラベグロン、ボトックス）、用途別（特発性過活動膀胱、神経性過活動膀胱）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界の女性の健康治療市場：市場規模・現状・予測
    Global Women Health Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N8208 2019年6月14日 94Pages
    当資料は、女性の健康治療のグローバル市場について調査・分析したレポートで、種類別（更年期障害、子宮内膜症、閉経後骨粗鬆症、乳がん、多嚢胞性卵巣症候群、その他）、用途別（画像診断センター、病院と診療所、ホームケア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...
  • 世界の膵がん治療市場：市場規模・現状・予測
    Global Pancreatic Cancer Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7757 2019年6月14日 99Pages
    当資料は、膵がん治療のグローバル市場について調査・分析したレポートで、種類別（生物学、化学療法、ターゲット療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    <...
  • 世界の酒さ治療薬市場：市場規模・現状・予測
    Global Rosacea Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7983 2019年6月14日 93Pages
    当資料は、酒さ治療薬のグローバル市場について調査・分析したレポートで、種類別（抗菌剤、アルファアゴニスト、レチノイド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界のシェーグレン症候群の治療薬市場：市場規模・現状・予測
    Global Sjogren's Syndrome Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N8047 2019年6月14日 99Pages
    当資料は、シェーグレン症候群の治療薬のグローバル市場について調査・分析したレポートで、種類別（一次、二次）、用途別（臨床、病院）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・シェーグレ...
  • 世界のプラスミノーゲンアクチベーター阻害剤1市場2019世界のプラスミノーゲンアクチベーター阻害剤1市場2019 The global Plasminogen Activator Inhibitor 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasminogen Activator Inhibitor 1 market status and forecast, categorizes the global Plasminogen …
  • 世界の脳卒中治療薬市場2019世界の脳卒中治療薬市場2019 Stroke is a disruption in brain function caused by lack of blood flow to the brain. The global Stroke Treatment Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report studies the global Stroke Treatme…
  • 世界の小児てんかん治療市場：市場規模・現状・予測世界の小児てんかん治療市場：市場規模・現状・予測 Epilepsy is one of the most common and challenging neurologic disorders affecting children.Pediatric epilepsies present particular challenges, including correct diagnoses, comorbidities and interactions with developmental processes in the brain. In 2018, the global Pediatric Epilepsy Therapeutics ma…
  • 世界の糖尿病性足部潰瘍治療薬市場：市場規模・現状・予測世界の糖尿病性足部潰瘍治療薬市場：市場規模・現状・予測 Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing br…
  • 世界のクローン病治療薬市場：市場規模・現状・予測世界のクローン病治療薬市場：市場規模・現状・予測 Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million …